Suppr超能文献

基于组学的女性癌症风险预测实施中的伦理、法律和监管问题:需考虑的要点。

Ethical, Legal, and Regulatory Issues for the Implementation of Omics-Based Risk Prediction of Women's Cancer: Points to Consider.

作者信息

Lévesque Emmanuelle, Kirby Emily, Bolt Ineke, Knoppers Bartha Maria, de Beaufort Inez, Pashayan Nora, Widschwendter Martin

机构信息

Center of Genomics and Policy, Department of Human Genetics, Faculty of Medicine, McGill University, Montréal, Québec,

Public Population Project in Genomics and Society (P³G), Montréal, Québec, Canada.

出版信息

Public Health Genomics. 2018;21(1-2):37-44. doi: 10.1159/000492663. Epub 2018 Sep 17.

Abstract

BACKGROUND AND OBJECTIVE

Advances in omics open new opportunities for cancer risk prediction and risk-based screening interventions. However, implementation of risk prediction in clinical practice may impact the ethical, legal, and regulatory aspects of current cancer screening programs. In order to support decision-making, we analyzed the ethical, legal, and regulatory issues and developed a set of Points to Consider to support management of these issues.

METHODS

We analyzed the legal and policy frameworks applicable to breast and cervical cancer screening programs in 7 European countries. We identified the most relevant issues to be considered, and we developed considerations for their management, based on the literature, the legal and policy frameworks, and our experience with similar issues.

RESULTS

The considerations focus on five topics: (A) health services planning, (B) information and invitation, (C) consent and data/sample collection, (D) risk calculation and communication of results, and (E) storage of data and residual samples.

CONCLUSION

Current frameworks might not be adequate to implement a risk prediction approach using omics factors due to the different characteristics of such approaches.

摘要

背景与目的

组学技术的进步为癌症风险预测和基于风险的筛查干预带来了新机遇。然而,在临床实践中实施风险预测可能会影响当前癌症筛查项目的伦理、法律和监管层面。为支持决策制定,我们分析了伦理、法律和监管问题,并制定了一套“考虑要点”以支持对这些问题的管理。

方法

我们分析了适用于7个欧洲国家乳腺癌和宫颈癌筛查项目的法律和政策框架。我们确定了最相关的需考虑问题,并基于文献、法律和政策框架以及我们处理类似问题的经验,制定了对这些问题的管理考量。

结果

这些考量聚焦于五个主题:(A)卫生服务规划,(B)信息与邀请,(C)同意与数据/样本收集,(D)风险计算与结果沟通,以及(E)数据与剩余样本的存储。

结论

由于基于组学因素的风险预测方法具有不同特点,当前框架可能不足以实施此类方法。

相似文献

9
Influence of qualitative research on women's health screening guidelines.定性研究对妇女健康筛查指南的影响。
Am J Obstet Gynecol. 2014 Jan;210(1):44.e1-6. doi: 10.1016/j.ajog.2013.09.021. Epub 2013 Sep 18.

引用本文的文献

8
Ethical Issues in Research and Development of Epigenome-wide Technologies.表观基因组技术研发中的伦理问题
Epigenet Insights. 2020 Apr 13;13:2516865720913253. doi: 10.1177/2516865720913253. eCollection 2020.

本文引用的文献

4
Global variation in gene expression and the value of diverse sampling.基因表达的全球差异及多样采样的价值
Curr Opin Syst Biol. 2017 Feb;1:102-108. doi: 10.1016/j.coisb.2016.12.018. Epub 2017 Mar 3.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验